Gujarat Fluorochemicals Limited
Momentum (94/100) does the heavy lifting; valuation (12/100) is the drag.
ExpensiveOvervaluedStocksWizard rates Gujarat Fluorochemicals Limited a Sell, scoring 41/100 on our blended model. At ₹4,582.1 it trades above our blended DCF and relative-multiples fair value of ₹2,480.51, about 46% downside to that estimate — we read it as overvalued by 46%. On 75.0x trailing earnings it sits pricier than the Chemicals median of about 41.0x. It's trading right at its 52-week high of ₹4,607.1. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9. The average analyst target of ₹3,897 implies about 15% downside across 16 analysts. It clears 7 of 13 investability checks, with durability 46, valuation 23 and momentum 94 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹1,984.41.
Analyst views
1-year price
EOD · 2026-07-2952-week range
-0.54% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell41Piotroski F-score 5/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Fail: ROE above 15%: 7.5%
- Pass: Low debt (D/E < 0.5): 0.29x
- Fail: Positive free cash flow
- Pass: Revenue growth > 10%: 12%
- Fail: Earnings growing: -43%
- Pass: Net margin ≥ 10%: 11.6%
- Pass: Current ratio > 1.5: 1.72
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Pass: Above 200-day average
- Pass: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 7.46
- Fail: Piotroski ≥ 7: 5/9
Quarterly results
Annual financials
Shareholding
- Promoter66.5%
- Institutions13.6%
- Public & other19.9%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Lightly leveraged balance sheet.
- Trading near its 52-week high.
- Financially solid — Altman Z 7.46.
Bear case
Weaknesses
- Low return on equity (7.5%).
Threats
- Earnings contracting year on year.
- Rich valuation versus sector peers.
- Trades ~46% above our estimated fair value.
About Gujarat Fluorochemicals Limited
Gujarat Fluorochemicals Limited manufactures and trades refrigerant gases, fluorochemicals, fluoropolymers, and battery chemicals, alongside wind and renewable energy solutions across India, Europe, the United States, and internationally. Its product portfolio includes caustic soda, carbon tetrachloride, chlorine, methylene dichloride, hydrochloric acid, sodium hydrogen sulphate, hydrogen gas, fluorspar, chloroform, and anhydrous hydrogen chloride.
Gujarat Fluorochemicals Limited — frequently asked questions
Is Gujarat Fluorochemicals Limited a buy, hold or sell?
StocksWizard currently rates Gujarat Fluorochemicals Limited (FLUOROCHEM) a Sell, based on a blended score of 41/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Gujarat Fluorochemicals Limited's fair value?
Our blended DCF and relative-valuation model estimates Gujarat Fluorochemicals Limited's fair value at about ₹2,480.51, versus a current price of ₹4,582.1 — roughly 46% downside. On that basis the stock looks overvalued by 46%.
Is Gujarat Fluorochemicals Limited financially healthy?
Gujarat Fluorochemicals Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 5/9.
How has Gujarat Fluorochemicals Limited's share price performed?
Gujarat Fluorochemicals Limited is up 27% over three months, and last traded at ₹4,582.1. Past performance doesn't predict future returns.
More in Chemicals
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.